About Us > Overview

ProtAffin is developing a novel approach within the field of biopharmaceuticals and aims to translate world-class science in understanding of protein-glycan interactions into products addressing medical conditions in respiratory medicine, inflammation and oncology. The company has 24 employees located in Graz, Austria and in London, UK. The Company also has a leading global network of advisors that will support the long-term commercial success of the business.

About Us
ProtAffin in the News

16 February 2012

CEO Jason Slingsby speaks at a recent SCRIP Round Table. Website

Complete News Archive »